Job/Unit: O43297
/KAP1
Date: 11-11-14 13:25:09
Pages: 6
Catalytic Asymmetric Alkylation of Aryl Heteroaryl Ketones
18066–18069; d) for examples with trifluoromethyl ketones as
Acknowledgments
substrates, see: S. L. X. Martina, R. B. C. Jagt, J. G. de Vries,
B. L. Feringa, A. J. Minnaard, Chem. Commun. 2006, 4093–
4095; V. R. Jumde, S. Facchetti, A. Iuliano, Tetrahedron: Asym-
metry 2010, 21, 2775–2781; R. Luo, K. Li, Y. Hu, W. Tang,
Adv. Synth. Catal. 2013, 355, 1297–1302; V. Valdivia, I.
Fernández, N. Khiar, Org. Biomol. Chem. 2014, 12, 1211–121;
e) for examples with isatins as substrates, see: R. Shintani, M.
Inoue, T. Hayashi, Angew. Chem. Int. Ed. 2006, 45, 3353–3356;
Angew. Chem. 2006, 118, 3431–3434; P. Y. Toullec, R. B. C.
Jagt, J. G. de Vries, B. L. Feringa, A. J. Minnaard, Org. Lett.
2006, 8, 2715–2718; f) for intramolecular examples, see: G. M.
Gallego, R. Sarpong, Chem. Sci. 2012, 3, 1338–1342; D. W.
Low, G. Pattison, M. D. Wieczysty, G. H. Churchill, H. W.
Lam, Org. Lett. 2012, 14, 2548–2551.
Financial support from the Netherlands Organisation for Scientific
Research (NWO) through a VIDI and ECHO grant is gratefully
acknowledged. The authors thank Davide Angelone for useful dis-
cussions regarding the DFT calculations.
[1] D. Ameen, T. J. Snape, Med. Chem. Commun. 2013, 4, 893–
907.
[2] a) P. Duchene-Marullaz, D. Jovanovic, N. Busch, J. Vacher,
Arch. Int. Pharmacodyn. Ther. 1963, 141, 465; b) Y. M. Roland,
U. S. 3145204, 1964.
[3] a) A. Bazex, A. Dupre, B. Christol, Clinique (Paris, France)
1963, 58, 447–450; b) P. R. Uldall, J. N. Walton, D. J. Newell,
Br. Med. J. 1961, 1, 1649–1652.
[4] a) N. Nuangchamnong, J. Niebyl, Int. J. Womens Health 2014,
6, 401–409; b) J. P. Vande Griend, S. L. Anderson, J. Am.
Pharm. Assoc. 2012, 52, 210–219.
[15] a) For examples of intramolecular addition, see: G. Liu, X. Lu,
J. Am. Chem. Soc. 2006, 128, 16504–16505; b) G. Liu, X. Lu,
Tetrahedron 2008, 64, 7324–7330; c) for examples with isatins
as substrates, see: Z. Liu, P. Gu, M. Shi, P. McDowell, G. Li,
Org. Lett. 2011, 13, 2314–2317.
[5] A. Ebnöther, H. P. Weber, Helv. Chim. Acta 1976, 59, 2462–
2468.
[16] C.-A. Chen, K.-H. Wu, H.-M. Gau, Angew. Chem. Int. Ed.
2007, 46, 5373–5376; Angew. Chem. 2007, 119, 5469–5472.
[17] E. Fernández-Mateos, B. Maciá, M. Yus, Eur. J. Org. Chem.
2014, 6519–6526.
[6] S. Dhillon, L. J. Scott, G. L. Plosker, CNS Drugs 2006, 20, 763–
790.
[7] L. Pu, H.-B. Yu, Chem. Rev. 2001, 101, 757–824.
[8] R. Noyori, S. Hashiguchi, Acc. Chem. Res. 1997, 30, 97–102.
[9] a) O. Riant, J. Hannedouche, Org. Biomol. Chem. 2007, 5, 873–
888; b) J. Christoffers, A. Baro (Eds.), Quaternary Stereo-
centres: Challenges and Solutions for Organic Synthesis Wiley-
VCH, Weinheim, Germany, 2006.
[18] R. D. Taylor, M. MacCoss, A. D. G. Lawson, J. Med. Chem.
2014, 57, 5845–5859.
[19] a) A. V. R. Madduri, A. J. Minaard, S. R. Harutyunyan, Org.
Biomol. Chem. 2012, 10, 2878–2884; b) A. V. R. Madduri, A. J.
Minaard, S. R. Harutyunyan, Chem. Commun. 2012, 48, 1478–
1480; c) A. V. R. Madduri, S. R. Harutyunyan, A. J. Minnaard,
Angew. Chem. Int. Ed. 2012, 51, 3164–3167; Angew. Chem.
2012, 124, 3218–3221.
[10] I. L. Styrniest, V. Bagutski, R. M. French, V. K. Aggarwal, Na-
ture 2008, 456, 778–782.
[11] a) M. Yus, D. J. Ramón, Recent Res. Dev. Org. Chem. 2002, 6,
297–378; b) D. J. Ramón, M. Yus, Chem. Rev. 2006, 106, 2126–
2208.
[20] No conversion to the desired product was observed in the ab-
sence of Lewis acids. From our previous research (unpublished
results) we found a combination of BF3·OEt2/CeCl3 to be the
best additive to activate ketones and to prevent 1,2-reduction.
[12] a) P. I. Dosa, G. C. Fu, J. Am. Chem. Soc. 1998, 120, 445–446;
b) M. Hatano, T. Miyamoto, K. Ishihara, Org. Lett. 2007, 9, [21] a) M. Hatano, S. Suzuki, K. Ishihara, J. Am. Chem. Soc. 2006,
4535–4538
128, 9998–9999; b) M. Hatano, S. Suzuki, K. Ishihara, Synlett
2010, 321–324; c) M. Hatano, T. Matsumura, K. Ishihara, Org.
Lett. 2005, 7, 573–576; d) G. Giacomelli, L. Lardicci, R. Santi,
J. Org. Chem. 1974, 39, 273.
[13] a) C. Garcia, P. J. Walsh, Org. Lett. 2003, 5, 3641–3644; b) O.
Prieto, D. J. Ramón, M. Yus, Tetrahedron: Asymmetry 2003,
14, 1955–1957; c) V. J. Forrat, O. Prieto, D. J. Ramón, M. Yus,
Chem. Eur. J. 2006, 12, 4431.
[14] a) T. Korenaga, A. Ko, K. Uotani, Y. Tanaka, T. Sakai, Angew.
Chem. Int. Ed. 2011, 50, 10703–10707; Angew. Chem. 2011,
123, 10891–10895; b) Y.-X. Liao, C.-H. Xing, Q.-S. Hu, Org.
Lett. 2012, 14, 1544–1547; c) for examples with α-keto esters
as substrates, see: H.-F. Duan, J.-H. Xie, X.-C. Qiao, L.-X.
Wang, Q.-L. Zhou, Angew. Chem. Int. Ed. 2008, 47, 4351–4353;
Angew. Chem. 2008, 120, 4423–4425; F. Cai, X. Pu, X. Qi, V.
Lynch, A. Radha, J. M. Ready, J. Am. Chem. Soc. 2011, 133,
[22] T. Laird, Comprehensive Organic Chemistry (Eds.: D. Barton,
W. D. Ollis, J. F. Stoddart), Pergamon Press, Oxford, UK, 1979,
vol. 1, chapter 5.4, p. 1174–1181.
[23] T. Imamoto, N. Takiyama, K. Nakamura, T. Hatajima, Y. Ka-
miya, J. Am. Chem. Soc. 1989, 111, 4392–4398.
[24] M. A. Fernández-Ibáñez, B. Maciá, A. J. Minnaard, B. L.
Feringa, Chem. Commun. 2008, 22, 2571–2573.
Received: October 6, 2014
Published Online:
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5